Market cap
$17 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
306.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-10.2 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-1.3
-
Debt to Equity
0
-
Book Value
$-1.8
-
EPS
$-2.9
-
Face value
--
-
Shares outstanding
10,789,546
10 Years Aggregate
CFO
$-247.33 Mln
EBITDA
$-313.07 Mln
Net Profit
$-312.64 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pluri Inc (PLUR)
| -48.8 | -6.7 | -35.2 | -68.1 | -35.1 | -42.5 | -19.7 |
|
BSE Sensex*
| -9.2 | -1.4 | 2.8 | -3.7 | 5.7 | 6.2 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Pluri Inc (PLUR)
| -30.1 | 625.2 | -38.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Pluri Inc (PLUR)
|
1.5 | 16.5 | 1.1 | -26.2 | -2,456.9 | -- | -- | 306.6 |
| 84.9 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 247.9 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 72.1 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 54.5 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 105.4 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 351.5 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 533.8 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 600.7 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 344.8 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Pluri Inc (PLUR)
Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates... for the treatment of inflammatory, muscle injuries, and hematologic conditions; and immunotherapy platform. Its product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acute muscle injuries following hip fracture, acute respiratory distress syndrome due to coronavirus Disease (COVID-19), peripheral artery disease, intermittent claudication, and critical limb ischemia; PLX-R18, composed of fetal MSC like cells originating from the placenta for the treatment of hematopoietic complications of the H-ARS, and is in Phase I clinical trial to treat hematopoietic cell transplantation; and allogeneic MAIT cell therapy platform. The company also offers cell manufacturing services and cell-based coffee; and develops and commercializes cultivated meat products. It operates in the field of regenerative medicine, food tech, immunotherapy, CDMO, and AgTech. It has collaboration agreement with Bar-Ilan University to advance cancer immunotherapy for solid tumors. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel. Read more
-
President, CEO & Director
Mr. Yaacov Yanay
-
President, CEO & Director
Mr. Yaacov Yanay
-
Headquarters
Haifa
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Pluri Inc (PLUR)
What is the current share price of Pluri Inc (PLUR) Today?
The share price of Pluri Inc (PLUR) is $1.53 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Pluri Inc (PLUR) has given a return of -35.11% in the last 3 years.
What is the current PB & PE ratio of Pluri Inc (PLUR)?
Since, TTM earnings of Pluri Inc (PLUR) is negative, P/E ratio is not available.
The P/B ratio of Pluri Inc (PLUR) is 306.56 times as on 28-Aug-2026, a 5818 premium to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-1.73 |
-5.71 |
2024 |
-1.50 |
325.61 |
2023 |
-0.15 |
0.31 |
2022 |
-0.12 |
0.16 |
2021 |
-0.29 |
0.26 |
What is the 52 Week High and Low of Pluri Inc (PLUR)?
The 52-week high and low of Pluri Inc (PLUR) are Rs 5.30 and Rs 1.45 as of 31-Aug-2026.
What is the market cap of Pluri Inc (PLUR)?
Pluri Inc (PLUR) has a market capitalisation of $ 17 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Pluri Inc (PLUR)?
Before investing in Pluri Inc (PLUR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.